Naltrexone and Vivitrol for Alcohol Use Disorder in Idaho: What You Need to Know

By Eric Arzubi, MD — Board-Certified Psychiatrist, Assistant Clinical Professor at Yale School of Medicine, CEO of Frontier Psychiatry

Most people with alcohol use disorder in Idaho are not getting treatment. That is not because they are in denial. It is usually because the version of treatment they picture does not fit their life.

A 30-day inpatient stay is not realistic for a lot of people. They have jobs, kids, fields to tend, or a small town where stepping away is not simple. Some are not ready for total abstinence today, but they know their drinking has become a problem. Some want treatment that is private, medical, and practical.

Naltrexone is a real option for those people. It is an FDA-approved medication for alcohol use disorder. It is not a controlled substance. It is not habit-forming. It comes as a daily pill or a once-monthly injection called Vivitrol. For the right person, it can reduce cravings, lower alcohol's reward response in the brain, and make it meaningfully easier to drink less or stop entirely.

At Frontier Psychiatry, we evaluate and treat alcohol use disorder by telehealth across Idaho. If you live in Boise, Meridian, Nampa, Idaho Falls, Twin Falls, Pocatello, or a smaller community hours from the nearest psychiatrist, you can talk with a licensed provider from home.

Here is what you need to know.

Key facts at a glance

• You do not have to go to rehab to get evidence-based treatment for alcohol use disorder.
• Naltrexone reduces alcohol's reward effect in the brain. It does not make you sick if you drink.
• Oral naltrexone is a daily pill. Vivitrol is the same medication given as a monthly injection.
• Telehealth can handle the evaluation and prescription for oral naltrexone in Idaho.
• Naltrexone is not right for people currently using opioids or those with certain liver conditions.

Idaho Has a Serious Alcohol Treatment Gap

About 11.56% of Idahoans age 12 and older meet criteria for alcohol use disorder, according to the Idaho Office of Drug Policy's 2024 Substance Use Disorder Needs Assessment. That is roughly in line with the national average. But the treatment picture is worse than the prevalence numbers suggest.

Only 6.93% of Idahoans receive specialty substance use disorder treatment, slightly below the national average of 7.20%. That gap represents more than 170,000 people who need specialized alcohol treatment and are not getting it.

Among adults ages 18 to 25, the numbers are more striking. The AUD rate in that age group climbs to nearly 18%, placing Idaho among the highest-prevalence states in the country for young adult alcohol use disorder. The treatment gap for that group is nearly as wide as the prevalence itself.

The economic cost of untreated AUD in Idaho is estimated at $1.536 billion annually in alcohol-related harm, according to the same needs assessment.

The Real Reason for the Gap

The treatment gap is not mostly about people refusing help. It is about a treatment system that has historically offered one dominant model: residential rehab or intensive outpatient programs built around group counseling and abstinence from day one.

That model works for some people. But it requires time off work, childcare coverage, geographic access, and often a level of readiness that many people are not at when they first recognize a problem. When the only visible option feels impossible, most people do nothing.

Medication changes that equation. It allows treatment to begin earlier, more privately, and without requiring someone to put their life on hold.

What Is Naltrexone and How Does It Work?

Naltrexone is a medication that reduces the rewarding effects of alcohol. It works by blocking opioid receptors in the brain, specifically the ones involved in the pleasure and reinforcement response that drinking triggers. When those receptors are blocked, alcohol stops delivering its usual payoff. The craving response weakens. Heavy drinking becomes less reinforcing over time.

It is not Antabuse. Naltrexone does not cause a physical reaction if you drink. It does not make you sick. It simply reduces the neurological reward that drives compulsive drinking, which is different from punishing you for drinking.

It is also not a controlled substance and is not habit-forming. That distinction matters for people who are cautious about adding another dependency to the picture.

What Naltrexone Can Help With

Naltrexone is useful across a range of goals, which is one reason it fits more people than traditional programs do:

• Reducing the number of heavy drinking days
• Lowering overall alcohol consumption
• Decreasing cravings and the urge to drink
• Supporting sobriety after quitting
• Helping people who are not ready to quit entirely start cutting back

That last point is important. Not everyone begins treatment with a goal of permanent abstinence. Naltrexone can be a useful tool even when the initial goal is harm reduction rather than complete sobriety, depending on how it is prescribed and managed.

Oral Naltrexone vs. Vivitrol: What Is the Difference?

Oral naltrexone and Vivitrol contain the same active medication. The difference is the delivery method, and that difference has real clinical implications.

The most meaningful real-world difference is adherence. A pill only works if you take it every day. When motivation fluctuates, which it does for most people managing a substance use disorder, daily pills can get skipped. The monthly injection removes that variable. Once it is administered, the medication is in your system for the full 28-day cycle regardless of how you feel about it on day 12.

That does not automatically make Vivitrol the better option. Some people want the control of a daily medication. Others want to start with the pill, assess how they respond, and decide whether the injectable form makes more sense for their lifestyle.

One Important Consideration Before Starting Vivitrol

Vivitrol requires preparation before the first injection. Because naltrexone blocks opioid receptors completely, it will trigger sudden, severe opioid withdrawal in anyone who has opioids in their system. This is a serious medical safety concern, not a minor side effect.

Before the first Vivitrol injection, a provider needs to confirm you have stopped drinking and are not currently using opioids. For oral naltrexone, the protocol is more flexible, though the same opioid contraindication applies. Your provider will walk through this with you during the evaluation.

What the Clinical Evidence Actually Shows

Naltrexone is not a fringe or experimental treatment. It has been FDA-approved for alcohol use disorder since 1994, and Vivitrol has been approved for alcohol dependence since 2006. The evidence base spans decades of randomized controlled trials, meta-analyses, and real-world outcomes data.

Key findings from independent research

Vivitrol's pivotal clinical trial enrolled 624 patients with alcohol dependence in an outpatient setting over six months. Patients who received Vivitrol alongside counseling had 25% fewer heavy drinking days per month compared to those who received placebo and counseling. Among patients who had been completely abstinent for at least one week before their first injection, 41% remained fully alcohol-free for the entire six-month study, compared to 17% in the placebo group.

A 2025 randomized clinical trial published in JAMA Internal Medicine compared oral and extended-release injectable naltrexone in patients hospitalized with alcohol use disorder. Both forms produced substantial reductions in heavy drinking days. Patients in both groups dropped from roughly 67 to 71% heavy drinking days at baseline to around 23 to 27% at three-month follow-up. That is a dramatic reduction by any clinical standard.

A 2025 study published in PMC analyzed more than 52,000 emergency department encounters involving patients who screened positive for hazardous drinking or active AUD and had no contraindications to naltrexone. Only 0.5% received a naltrexone prescription at discharge. This is not a finding about the medication's effectiveness. It is a finding about how rarely eligible patients are offered it, even in clinical settings where they are already receiving care.

The bottom line: Naltrexone works. The evidence is strong, the mechanism is well understood, and the medication has been in clinical use for over 30 years. The problem is not the drug. It is that most eligible patients are never offered it.

Why Naltrexone Is Still Underused

Given the strength of the evidence, the underuse of naltrexone is one of the more frustrating gaps in American healthcare.

The 2025 emergency department study cited above makes the point clearly: even when patients present to a hospital with alcohol-related problems, have no contraindications, and are already in the care of a provider, fewer than 1 in 200 leave with a naltrexone prescription. The same study noted that AUD medications are "not typically initiated" even during inpatient hospital stays.

There are a few systemic reasons for this.

Primary care and hospital medicine have limited addiction training

Most physicians are not trained in addiction medicine and are not comfortable initiating pharmacotherapy for AUD. That is not a criticism; it reflects how medical education has historically been structured. The result is that patients who interact with the healthcare system for alcohol-related reasons are often discharged without ever being told a medication option exists.

The rehab model has dominated public perception

When most people hear "alcohol treatment," they picture inpatient rehab, 12-step programs, or intensive outpatient programs. Those are real and sometimes appropriate options. But they are not the only evidence-based options, and they have crowded out public awareness of medication-based treatment for decades.

Geography compounds the problem in Idaho

In rural and frontier communities, the nearest addiction specialist may be hours away or nonexistent. Patients who might benefit from a straightforward evaluation and prescription never get one because the access point does not exist locally. As we discuss below, telehealth changes this for a significant portion of Idaho residents.

As we've written about in more depth, naltrexone remains one of the most underutilized treatments for alcohol use disorder in rural America, and the reasons are systemic rather than clinical.

The Sinclair Method: What It Is and What to Know

The Sinclair Method refers to taking oral naltrexone specifically before drinking, rather than on a fixed daily schedule. The idea, developed by researcher Dr. David Sinclair, is that blocking alcohol's reward response at the moment of drinking may gradually weaken the brain's learned association between drinking and pleasure. Over time, the craving itself is supposed to diminish without requiring a formal quit date.

This approach has attracted significant interest online, particularly among people who feel stuck between "I'm not ready to stop completely" and "I know I need to do something."

What the evidence actually supports

The Sinclair Method is not a separate FDA-approved protocol. It is a specific application of oral naltrexone, drawing on the same pharmacology as standard daily dosing. Some clinicians use it, and there is patient-reported evidence suggesting it helps certain people reduce drinking over time.

That said, the research base for TSM as a distinct protocol is less standardized than the evidence for standard naltrexone use. Much of what circulates online about TSM success rates comes from patient communities and advocacy sources rather than peer-reviewed trials designed to test the method directly. That does not mean the approach is ineffective, but it does mean the claims should be weighed carefully.

The practical takeaway for patients:

• If you are not ready to commit to abstinence, that does not mean you cannot start treatment.
• Oral naltrexone can be used in ways that allow for gradual reduction rather than immediate stopping.
• The right dosing protocol for your situation is a clinical decision, not something to self-prescribe based on forum posts.

If the Sinclair Method interests you, it is worth raising directly with a prescriber during your evaluation. A provider can discuss whether it is appropriate for your specific situation and what follow-up would look like.

Who Is a Good Candidate for Naltrexone or Vivitrol?

Naltrexone is appropriate for a wide range of people dealing with heavy drinking or alcohol use disorder. It is not a last resort for the most severe cases. It is a first-line medication option that can be used early in treatment.

You may be a good candidate if you:

• Drink more than you want to and want medical help reducing or stopping
• Have tried to cut back on your own and keep returning to the same pattern
• Cannot or will not do inpatient or residential treatment
• Want a private, outpatient option that does not require time off work
• Have been diagnosed with alcohol use disorder and want medication support alongside counseling or therapy
• Are not currently using opioids

Naltrexone is not appropriate if you:

• Currently use opioids or have a physical dependence on opioid medications or illicit opioids. This is a serious safety concern. Naltrexone will trigger acute opioid withdrawal in anyone with opioids in their system.
• Have significant liver disease or hepatitis. Naltrexone is metabolized by the liver, and your provider will review liver function before prescribing.
• Are pregnant or planning to become pregnant. The risk-benefit discussion requires careful clinical judgment.
• Are allergic to naltrexone or components of the Vivitrol injectable formulation.

This is exactly why a proper evaluation matters. Starting naltrexone safely requires a review of your drinking history, medical history, current medications, liver health, and any opioid use. That review is what a telehealth psychiatric evaluation provides. It is not a formality. It is what makes the treatment safe.

Can You Get Naltrexone Through Telehealth in Idaho?

Yes, in most cases.

Naltrexone is not a controlled substance, which makes telehealth prescribing more straightforward than many other addiction medications. Under federal telehealth flexibilities extended through December 31, 2026 by the DEA and HHS, a licensed provider can prescribe oral naltrexone following a telehealth evaluation without an initial in-person visit.

For Idaho residents, this matters for two reasons.

Distance. Many Idaho communities do not have a local addiction psychiatrist or prescriber trained in AUD pharmacotherapy. The nearest specialist may be hours away. Telehealth makes it possible to get a real clinical evaluation and prescription from home.

Privacy. In small towns, people know each other. Not everyone wants to be seen walking into a local treatment program or clinic. A telehealth visit from your own home, on your own schedule, removes that barrier entirely.

What telehealth can and cannot handle

Oral naltrexone can be prescribed entirely through telehealth. The prescription goes to a pharmacy of your choice.

Vivitrol still requires an in-person injection, administered by a qualified healthcare professional. Telehealth can manage the evaluation, treatment planning, and ongoing follow-up, but the monthly shot itself needs to happen in person. At Frontier Psychiatry, we help coordinate injection sites for Idaho patients who choose Vivitrol.

A note on insurance coverage in Idaho

Vivitrol is FDA-approved and covered by most major insurance plans, including Idaho Medicaid. Coverage varies by plan, and prior authorization may be required. Oral naltrexone is widely available as a generic and is typically low-cost even without insurance. Our team can help navigate coverage and prior authorization as part of your care.

How Frontier Psychiatry Treats Alcohol Use Disorder in Idaho

Frontier Psychiatry provides telehealth psychiatric evaluations and treatment for alcohol use disorder across Idaho, including Boise, Meridian, Nampa, Idaho Falls, Pocatello, Twin Falls, and rural communities without local psychiatric access.

Here is what the process looks like from first contact to ongoing care.

Step 1: Telehealth evaluation You meet with a licensed provider by video. No referral is required. We review your drinking history, medical history, current medications, treatment goals, and any factors that could affect whether naltrexone is safe and appropriate for you. This is a real clinical evaluation, not a checklist.

Step 2: Treatment planning If naltrexone or Vivitrol is appropriate, your provider walks you through both options clearly: how each one works, what the preparation protocol looks like (especially for Vivitrol), and what follow-up will involve. We also discuss whether co-occurring conditions like anxiety, depression, or trauma should be addressed alongside AUD. Both are common and can affect treatment outcomes if left unaddressed.

Step 3: Prescription or injection coordination For oral naltrexone, we send the prescription electronically to a pharmacy of your choice. For Vivitrol, we coordinate with a local provider who can administer the monthly injection while we continue managing your care by telehealth.

Step 4: Ongoing psychiatric follow-up We follow up regularly to monitor your response, adjust the approach if needed, and support any co-occurring mental health conditions. Alcohol use disorder rarely travels alone. Good treatment accounts for the full picture.

No referral is required to schedule with Frontier Psychiatry. No prior treatment history is required. If you are in Idaho and want to find out whether naltrexone or Vivitrol is right for you, you can start today.

Frequently Asked Questions

Does naltrexone work for alcohol use disorder?

Yes. Naltrexone is one of the most thoroughly studied medications for alcohol use disorder and is recommended in SAMHSA's clinical guidelines as a first-line treatment. It reduces heavy drinking days and can support sobriety, especially when combined with counseling or follow-up care.

What is the difference between naltrexone and Vivitrol?

Vivitrol is the extended-release injectable form of naltrexone. Oral naltrexone is a pill taken once daily. Vivitrol is administered as a single monthly injection. Both contain the same active medication and work by the same mechanism. The difference is delivery and adherence.

Do I need to go to rehab before I can take naltrexone?

No. Many people start naltrexone as outpatient treatment and never attend inpatient rehab. Rehab may still be the right level of care for some people, but it is not a prerequisite for medication-based treatment.

Can a psychiatrist prescribe naltrexone by telehealth?

Yes. In most cases, a licensed psychiatrist or psychiatric provider can prescribe oral naltrexone through telehealth after a proper evaluation. Vivitrol requires an in-person injection, but telehealth handles the evaluation, planning, and ongoing management.

Do I have to stop drinking before starting naltrexone?

It depends on the form and your clinical situation. Oral naltrexone can sometimes be started while someone is still drinking, depending on the treatment plan and safety factors. Vivitrol requires stopping drinking before the first injection. Your provider will give you specific guidance based on your history.

Is naltrexone addictive?

No. Naltrexone is not habit-forming and is not classified as a controlled substance.

How long does it take naltrexone to work?

Most people begin to notice changes in cravings or drinking behavior within the first few weeks. The full effect, particularly the gradual reduction in craving patterns, develops over several months of consistent use. Most treatment protocols recommend at least three to six months of use to see the full benefit.

What happens if I drink while on Vivitrol?

Vivitrol blocks the rewarding effects of alcohol, so drinking while on Vivitrol is less reinforcing than usual. You will not have a severe physical reaction the way you would with Antabuse. However, drinking while on Vivitrol is not recommended, and the medication works best when combined with a commitment to reduce or stop drinking and with ongoing clinical support.

Is Vivitrol covered by insurance in Idaho?

Vivitrol is FDA-approved and covered by most major insurance plans, including Idaho Medicaid. Coverage and prior authorization requirements vary by plan. Our team can help with prior authorization if needed. Generic oral naltrexone is typically available at low cost even without insurance.

The Bottom Line

More than 170,000 Idahoans need alcohol use disorder treatment and are not getting it. Some of them are waiting for a reason to try. Some of them do not know a medical option exists that fits their life.

Naltrexone and Vivitrol will not work for everyone. But for the right person, someone who drinks more than they want to, who is not ready for rehab, who wants a clinical approach that meets them where they are, these medications can be genuinely life-changing.

Key takeaways

• Naltrexone is FDA-approved, non-habit-forming, and available without going to rehab.
• Both oral and injectable forms are evidence-based. The better one is the one you can actually start and stick with.
• Telehealth makes evaluation and prescription accessible across Idaho, including rural communities.
• You do not have to be ready to quit forever to start a conversation with a prescriber.

Frontier Psychiatry offers telehealth psychiatric evaluations for alcohol use disorder across Idaho. No referral needed. No waiting list. If you are in Boise, Twin Falls, Pocatello, or anywhere in the state and want to find out whether naltrexone or Vivitrol is right for you, schedule your first visit today.

Sources: Idaho Office of Drug Policy, 2024 Substance Use Disorder Needs Assessment; SAMHSA, Naltrexone Clinical Guidelines; FDA Drug Approval Database, Naltrexone; JAMA Internal Medicine, 2025: Oral vs. Extended-Release Injectable Naltrexone for Hospitalized Patients with AUD; PMC, 2025: Predictors of Naltrexone Prescribing for AUD in the Emergency Department; Idaho Department of Health and Welfare, Behavioral Health and Substance Use Disorder